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To the Editor: Covic et al describe attempts to measure
“central arterial pressure waveforms” in hemodialysis
Reply from the authorpatients in Romania [1]. They claim their noninvasive
assessments of “aortic” blood pressure (BP) waveforms We thank Dr. Eldon Lehmann for his letter and the
using the SphygmoCor device (PWV Medical, Inc., Syd- interest he has shown in our recent publication [1].
ney, Australia) have been validated. However, they cite Over the last 2 years Dr. Lehmann, a noted expert in
no data to support this assertion. vascular imaging and methodology, with a long-standing
The authors write, “The software analytical program interest in arterial compliance, has repeatedly censured
also derived in real time from the measured radial artery other authors of other studies in which similar methods
waveform an aortic BP waveform using a validated trans- have been used [2–4].
fer function algorithm” [1, p 2636]. However, this is not Interested readers are urged to follow this correspon-
correct. The two references cited (23 and 24) have noth- dence trail across time, and several journals, the better
ing to do with the SphygmoCor and have not validated to appreciate the background to these comments.
the SphygmoCor’s generalized transfer function (GTF) The thrust of his comments to us can be summarized
algorithm. as follows. First, is there any justification/supportive evi-
Reference 23 is a 2-page short report from a 1992 dence for the use of a reverse generalized energy transfer
Supplement, a year before both the SphygmoCor radial
function (GTF), as opposed to an individualized energy
artery GTF was published [2], and the technique’s
transfer function? Second, which parameters can safelyUnited States Patent was granted [3]. Reference 24 did
be derived using a validated-GTF? Third, has there beennot use the SphygmoCor, but rather involved another
any independent validation of the use of such GTFs withGTF developed using a completely different computa-
noninvasively calibrated brachial artery blood pressure?tional technique. This approach has subsequently been
Finally, have the methodology and algorithms in use inshown to be ineffective in 67% of cases, when calibrated
the SphygmoCor device (PWV Medical, Inc., Sydney,noninvasively [4].
Australia) been validated? Our answers (for brevity)A search on Medline reveals a paucity of validation
are, “yes; aortic systolic blood pressure and augmen-work with the SphygmoCor reported in the literature.
tation index; yes, but not yet in the public domain; andFurthermore, no evidence has been provided to support
partly.” We have reason to hope that later this year thethe use of the device in patients with renal failure, let
answer to all of the questions will be “yes.” Until then,alone in those following hemodialysis. Given this, re-
we concede that complete validation of this extremelysearchers may wish to exercise caution in making claims
interesting and potentially useful pulse wave analysisabout the “validity” of the noninvasive approach, which,
technique is (eagerly) awaited.at present, remains completely unproven, especially in
renal disease.
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